Guanfu Holdings(002102)2025-01-27 11:40Financial Performance Forecast - The company expects a net loss of between 400 million to 500 million CNY for the fiscal year 2024, a decline of 254.60% to 293.25% compared to a profit of 258.74 million CNY in the previous year[3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of 350 million to 450 million CNY, compared to a loss of 4.08 million CNY in the previous year[3]. - The basic earnings per share are expected to be a loss of 0.15 to 0.19 CNY per share, compared to a profit of 0.0982 CNY per share in the previous year[3]. Business Strategy and Operations - The vitamin E business is anticipated to generate profits of no less than 300 million CNY in Q4 2024, driven by a significant increase in market prices[5]. - The company plans to optimize its plastic trade e-commerce business structure, leading to the closure of underperforming subsidiaries and an expected goodwill impairment of 580 million to 630 million CNY[6]. - The company aims to focus on its core business in fine chemicals and enhance its R&D efforts in new products and technologies to maintain a competitive edge in the industry[6]. Asset Valuation and Financial Communication - The fair value assessment of investment properties is expected to decrease by 80 million to 120 million CNY due to a high vacancy rate resulting from the sale of park assets[6]. - The company has communicated its performance forecast with its auditing firm, and there are no discrepancies regarding the forecast[4]. - Investors are advised to exercise caution as the performance forecast is based on preliminary estimates and the final financial data will be disclosed in the annual report[7].